Figure 3: The relative numbers of PC9-mRFP cells in gefitinib-treated monocultures or cocultures with various CAF608 clones. | Scientific Reports

Figure 3: The relative numbers of PC9-mRFP cells in gefitinib-treated monocultures or cocultures with various CAF608 clones.

From: CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors

Figure 3

(A) Fluorescence images of 6 clones derived from the CAF608 parent population. (B) The percent of control of viable PC9-mRFP cells cocultured with various CAF608 clones after gefitinib treatment.

Back to article page